Table 1 Demographics and health characteristics among the study population, stratified by syringe service program use
From: Injections and infections: understanding syringe service program utilization in a rural state
Overall n = 101 | SSP usea n = 65 | No SSP use n = 36 | p valueb | |
|---|---|---|---|---|
Demographics | ||||
Femalec | 56 (55%) | 40 (62%) | 16 (44%) | 0.10 |
Mean age (SD) | 36 (7) | 36 (8) | 36 (6) | 0.94 |
Caucasian | 95 (94%) | 61 (94%) | 34 (94%) | 1.0 |
Insuranced | ||||
Medicaid | 60 (61%) | 39 (61%) | 21 (60%) | 0.13 |
Medicare | 6 (6%) | 6 (9%) | 0 | |
Dual Medicare/Medicaid | 3 (3%) | 3 (5%) | 0 | |
Commercial | 5 (5%) | 2 (3%) | 3 (9%) | |
Uninsured | 25 (25%) | 14 (22%) | 11 (31%) | |
Primary care provider | 68 (67%) | 48 (74%) | 20 (56%) | 0.06 |
History of incarcerationc | 90 (89%) | 61 (94%) | 29 (81%) | 0.05 |
Experiencing homelessness | 46 (46%) | 36 (55%) | 10 (28%) | 0.01 |
Small/Isolated rural | 18 (18%) | 5 (8%) | 13 (36%) | < 0.01 |
> 10 miles from SSP | 57 (56%) | 28 (43%) | 29 (81%) | < 0.01 |
Health characteristics | ||||
Person with HIV | 1 (1%) | 1 (1.5%) | 0 (0) | 0.61 |
Hepatitis B infection | 8 (8%) | 6 (9%) | 2 (6%) | 0.71 |
Hepatitis C exposure | 73 (72%) | 50 (77%) | 23 (64%) | 0.16 |
Condomless sex | 76 (75%) | 46 (71%) | 30 (83%) | 0.16 |
Pregnant | 3 (3.0%) | 2 (3%) | 1 (3%) | 1.0 |
History of infectious complications | ||||
Endocarditis | 52 (51%) | 36 (55%) | 16 (44%) | 0.29 |
Skin/soft tissue infection | 31 (31%) | 21 (32%) | 10 (28%) | 0.64 |
Septic emboli | 26 (26%) | 19 (29%) | 7 (19%) | 0.28 |
Bacteremia/sepsis | 18 (56%) | 14 (22%) | 6 (17%) | 0.56 |
Septic joint | 11 (11%) | 7 (11%) | 4 (11%) | 1.0 |
Epidural abscess | 14 (14%) | 5 (8%) | 9 (25%) | 0.03 |
Osteomyelitis/Diskitis | 26 (26%) | 13 (20%) | 13 (36%) | 0.08 |
History of sexually transmitted infection | 27 (27%) | 21 (32%) | 6 (17%) | 0.09 |
Any mental health condition | 91 (90%) | 62 (95%) | 29 (81%) | 0.03 |
Charlson comorbidity index (1 or more) | 25 (24%) | 15 (23%) | 10 (28%) | 0.60 |
Hepatitis A vaccine completion | 58 (58%) | 39 (61%) | 19 (54%) | 0.52 |
Hepatitis B vaccine completion | 53 (53%) | 37 (58%) | 16 (44%) | 0.20 |
Tdap vaccination | 43 (43%) | 33 (51%) | 10 (28%) | 0.03 |